Research On The Strategic Development Of Ji Lin Dong Yi Pharmaceutical Group

Since China’s reform and opening up,with the continuous improvement of people’s living standards and the increasing emphasis on their own health,the market scale of China’s pharmaceutical industry has maintained rapid and steady growth.With the emergence of safety products such as vaccines and other biological drugs and medical devices in recent years,people are paying more and more attention to the production quality of the pharmaceutical industry.General Secretary Xi Jinping stressed the need to put people’s health in a strategic position of priority development.The state has also introduced a number of policies and laws related to the pharmaceutical industry in recent years.Jilin Dongyi Pharmaceutical Group started in 1999 and has formed a complete large health industry chain integrating R&D,production,circulation and medical services.It has the largest pharmaceutical health industrial park in Northeast China.In the face of the current innovation and development trend of China’s pharmaceutical industry,especially the supply-side reform,Jilin Dongyi Pharmaceutical Group faces new challenges and opportunities.Therefore,it is of great significance to use the strategic management thinking of enterprises to help Jilin Dongyi Pharmaceutical Group analyze and formulate its future development strategy.This paper collects data in the form of literature analysis,quantitative research method,interview research method,etc.and understands and analyzes the current situation of Jilin Dongyi Pharmaceutical Group.Firstly,based on the description of the relevant literature on the development strategy theory of modern pharmaceutical enterprises,this paper summarizes the research of scholars at home and abroad,and then evaluates the development status of Jilin Dongyi Pharmaceutical Group,and its problems and causes.Analyze.Secondly,the paper uses the PEST model to analyze the macroeconomic environment of Jilin Dongyi Pharmaceutical Group,which is currently facing political,economic,social,cultural and technological levels.Then,using the Porter Five Force Model to analyze the current industrial environment of Jilin Dongyi Pharmaceutical Group,Then,from the aspects of enterprise resources and capabilities,analyze the internal environment of Jilin Dongyi Pharmaceutical Group,and then use SWOT analysis tools to summarize the advantages,disadvantages,threats and opportunities in the development of Jilin Dongyi Pharmaceutical Group,and obtain the SWOT strategic combination table..Finally,the paper plans the development strategy goals of Jilin Dongyi Pharmaceutical Group,and makes the choice of enterprise development strategy and gives the implementation plan and safeguard measures of the enterprise strategy.Based on the theory of corporate strategic management,this paper realizes the rational planning of Jilin Dongyi Pharmaceutical Group in the regional market and the domestic market through the research of the development strategy of Jilin Dongyi Pharmaceutical Group,thus realizing the industrial transformation of Jilin Dongyi Pharmaceutical Group and ensuring society.At the same time of benefit,we will seize the historical opportunity of rapid and stable development of China’s pharmaceutical industry,increase the economic benefits of enterprises,and promote the sustainable development of enterprises.